The Machine Learning in Drug Discovery Symposium is returning on November 7, 2025! Tickets will be available soon.
This hybrid symposium highlights recent progress in the application of machine learning techniques to drug discovery and brings together researchers working in applying machine learning to target validation, hit identification and optimization, clinical trial design, biologics, and other areas of drug discovery for talks, poster sessions and networking.
For questions about the symposium or interest in sponsoring the 2025 symposium, reach out to mlinddsymposium@broadinstitute.org.
Keynote speaker
Tom Miller
Co-founder and Chief Executive Officer
Iambic Therapeutics